News & Events February

CTI Announces Commencement of Patient Enrollment in the Isotechnika ISA247 Phase IIB Clinical Program for the Prevention of Rejection following Kidney Transplantation

February 6, 2006

CTI Clinical Trial and Consulting Services (CTI) announced the beginning of patient enrollment in a Phase IIB clinical program of ISA247 for the prevention of organ graft rejection in patients undergoing kidney transplantation. CTI is managing the clinical trial program on behalf of Isotechnika Inc. Over the past twenty-five ...

Read More

Join Our Mailing List